PEDBASE.org - The Pediatric Database -
Detailed information of CONGENITAL TOXOPLASMOSIS
CONGENITAL TOXOPLASMOSIS
DEFINITION:
A contagious infectious disease caused by the protozoan
Toxoplasma gondii with ocular, central nervous system (CNS), and
systemic manifestations.
EPIDEMIOLOGY:
- incidence: 0.3-1/1000 live births
- age of onset:
- risk factors:
- exposure to toxoplasma gondii
PATHOGENESIS:
- the rate of transmission* is directly related to the
gestational age at the time of infection while the degree of
fetal damage has an inverse relationship:
- 1st trimester - 17% - spontaneous abortion
- 2nd trimester - 25% - spontaneous abortion or severe
disease
- 3rd trimester - 65% - subclinical disease
- acquired by the ingestion of raw or undercooked meat
(pigs, cattle), or of infectious oocysts in feces (cats,
birds)
2. Recurrent Maternal Infection
- maternal immunity appears to protect against
intrauterine transmission of this parasite and thus
congenital toxoplasmosis occurs only when the infection is
acquired during gestation (primary parasitemia)
- true except in women who are immunocomprimised (i.e.,
AIDS)
2. Background
- the congenital varient may run a fulminating course leading
to death in a matter of days or months
- poor prognosis and most symptomatic infants develop severe
CNS and ocular sequelae
- ingestion of oocysts or tissue cysts results in liberation
of organisms that invade the intestinal mucosa and are then
disseminated widely to tissues including the placenta and, after
a lag period, the fetus
- * average rate of transplacental transmission rate is 50% in
untreated pregnant women
- treatment of an infected mother during pregnancy reduces the
likelihood of congenital transmission
- prevention achieved by:
- thoroughly cooking meat
- washing fruits and vegetables
- wearing gloves when working in the garden or disposing of
cat litter
CLINICAL FEATURES:
- 70% of infants with congenital toxoplasmosis infection are
asymptomatic
- 30% of infants are symptomatic
1. Ocular Manifestations (76%)
- chorioretinitis
- optic nerve atrophy
- blindness
- ocular palsies
- icterus
- microphthalmias (Note: no cataracts)
2. CNS Manifestations (52%)
- microcephaly or hydrocephaly
- motor and intellectual retardation
- seizures
- sensorineuronal hearing loss
3. Systemic Manifestations
1. Reticuloendothelial (10%)
- hepatomegaly/splenomegaly, jaundice
- thrombocytopenia (with petechiae and purpura)
2. Others
- fever
- pneumonitis
- maculopapular rash
- IUGR, low birth weight, failure to thrive, poor feeding
INVESTIGATIONS:
1. Diagnostic
1. Virology
- gold standard
- isolation of T. gondii from placenta or cord blood
2. Serology
- Sabin-Feldman dye test
- measures IgG T. gondii antibody
- indirect fluorescent antibody test
- IgM fluorescent antibody test
2. Serum
- CBC - anemia, thrombocytopenia
- conjugated hyperbilirubinemia, unconjugated
hyperbilirubinemia
- elevated hepatic transaminases
3. CSF
- xanthochromia, elevated protein, mixed pleocytosis
4. Imaging Studies
1. CT (Head)
- intracranial calcifications (33%)
- of basal and/or periventricular regions
- encephalomalacia, hydrocephalus, parenchymal lesions
MANAGEMENT:
1. Medical
- combination of pyrimethamine with sulfadiazine or triple
sulfonamides
- side effects: teratogenic, bone marrow suppression
|
Pediatric Database - CONGENITAL TOXOPLASMOSIS
Pediatric Organization - Pedbase [at] Gmail.com